Yeah but that’s just it, the others didn’t have as good a “grasp” as they thought, or they were just deliberately disguising technical speak as down ramps, similarly to how your posts are structured as CE mark was awarded in the end. Much to their annoyance I’m certain.
Just on your reference to Novocure, not bad for a $7 billionUSD company to be to be using the OSL study template to advance their product...maybe you should put some money into them if your confidence is wearing thin here?
Ann: Oncosil breakthrough device receives CE Marking approval, page-156
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(4.76%) |
Mkt cap ! $41.62M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $36.16K | 3.384M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 14154999 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 5667943 | 6 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |